FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India.
Metrics to compare | FDC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFDCPeersSector | |
---|---|---|---|---|
P/E Ratio | 28.6x | 15.7x | −0.5x | |
PEG Ratio | −2.37 | 0.11 | 0.00 | |
Price/Book | 3.3x | 1.1x | 2.6x | |
Price / LTM Sales | 3.6x | 1.1x | 3.0x | |
Upside (Analyst Target) | - | 10.9% | 51.5% | |
Fair Value Upside | Unlock | 2.5% | 9.4% | Unlock |